Cabaletta Bio, Inc. (CABA)
Cabaletta Bio Market Cap: 240.66M for Dec. 9, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| CorMedix, Inc. | 915.53M |
| Verastem, Inc. | 762.24M |
| Anavex Life Sciences Corp. | 394.03M |
| Ocugen, Inc. | 377.91M |
| Cartesian Therapeutics, Inc. | 205.43M |
Market Cap Related Metrics
| PEG Ratio | -0.0575 |
| Price to Book Value | 1.726 |
| Price | 2.50 |
| Earnings Yield | -101.1% |
| PEGY Ratio | -0.0575 |